Epigenomic regulation of host-microbiota interactions

Trends in Immunology

Volumn 35, Issue 11, 2014, Pages 518-525

  Alenghat, Theresa ^a   Artis, David ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE;

DNA METHYLATION; DNA MODIFICATION; ENHANCER REGION; EPIGENETICS; GENETIC REGULATION; HEMATOPOIETIC CELL; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HOST PATHOGEN INTERACTION; HUMAN; INTESTINE EPITHELIUM; MICROENVIRONMENT; MICROFLORA; NONHUMAN; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; ANIMAL; BLOOD CELL; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENOTYPE ENVIRONMENT INTERACTION; HOMEOSTASIS; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; TUMOR MICROENVIRONMENT;

ANIMALS; BLOOD CELLS; CELLULAR MICROENVIRONMENT; EPIGENESIS, GENETIC; EPIGENOMICS; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; GENE-ENVIRONMENT INTERACTION; HISTONE DEACETYLASES; HOMEOSTASIS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTESTINAL MUCOSA; MICROBIOTA;

EID: 84925293456     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2014.09.007     Document Type: Review

References (93)

1. Renz H., et al. Gene-environment interactions in chronic inflammatory disease. Nat. Immunol. 2011, 12:273-277.
2. Slomko H., et al. Minireview: epigenetics of obesity and diabetes in humans. Endocrinology 2012, 153:1025-1030.
3. Mukherjee A.B., Zhang Z. Allergic asthma: influence of genetic and environmental factors. J. Biol. Chem. 2011, 286:32883-32889.
4. Strober W., et al. The fundamental basis of inflammatory bowel disease. J. Clin. Invest. 2007, 117:514-521.
5. Kau A.L., et al. Human nutrition, the gut microbiome and the immune system. Nature 2011, 474:327-336.
6. Kaser A., et al. Inflammatory bowel disease. Annu. Rev. Immunol. 2010, 28:573-621.
7. Ivanov I.I., Honda K. Intestinal commensal microbes as immune modulators. Cell Host Microbe 2012, 12:496-508.
8. Cadwell K., et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 2010, 141:1135-1145.
9. Kamada N., et al. Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 2013, 13:321-335.
10. Spasova D.S., Surh C.D. Blowing on embers: commensal microbiota and our immune system. Front. Immunol. 2014, 5:318.
11. Hill D.A., Artis D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu. Rev. Immunol. 2010, 28:623-667.
12. Duerkop B.A., et al. Immune responses to the microbiota at the intestinal mucosal surface. Immunity 2009, 31:368-376.
13. Kabat A.M., et al. Modulation of immune development and function by intestinal microbiota. Trends Immunol. 2014, 10.1016/j.it.2014.07.010.
14. Tremaroli V., Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012, 489:242-249.
15. Brestoff J.R., Artis D. Commensal bacteria at the interface of host metabolism and the immune system. Nat. Immunol. 2013, 14:676-684.
16. Musso G., et al. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu. Rev. Med. 2011, 62:361-380.
17. McLoughlin R.M., Mills K.H. Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma. J. Allergy Clin. Immunol. 2011, 127:1097-1107. quiz 1108-1099.
18. Arthur J.C., et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012, 338:120-123.
19. Happel N., Doenecke D. Histone H1 and its isoforms: contribution to chromatin structure and function. Gene 2009, 431:1-12.
20. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 1997, 389:349-352.
21. Arrowsmith C.H., et al. Epigenetic protein families: a new frontier for drug discovery. Nat. Rev. Drug Discov. 2012, 11:384-400.
22. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080.
23. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature 2000, 403:41-45.
24. Begin P., Nadeau K.C. Epigenetic regulation of asthma and allergic disease. Allergy Asthma Clin. Immunol. 2014, 10:27.
25. Feil R., Fraga M.F. Epigenetics and the environment: emerging patterns and implications. Nat. Rev. Genet. 2011, 13:97-109.
26. Handel A.E., et al. Epigenetics: molecular mechanisms and implications for disease. Trends Mol. Med. 2010, 16:7-16.
27. Hooper L.V., et al. Interactions between the microbiota and the immune system. Science 2012, 336:1268-1273.
28. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 2008, 8:411-420.
29. Gallo R.L., Hooper L.V. Epithelial antimicrobial defence of the skin and intestine. Nat. Rev. Immunol. 2012, 12:503-516.
30. Roda G., et al. Intestinal epithelial cells in inflammatory bowel diseases. World J. Gastroenterol. 2010, 16:4264-4271.
31. Dahan S., et al. Epithelia: lymphocyte interactions in the gut. Immunol. Rev. 2007, 215:243-253.
32. Littman D.R., Pamer E.G. Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe 2011, 10:311-323.
33. Khosravi A., et al. Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe 2014, 15:374-381.
34. Dimitriu P.A., et al. Temporal stability of the mouse gut microbiota in relation to innate and adaptive immunity. Env. Microbiol. Rep. 2013, 5:200-210.
35. Bierne H., et al. Epigenetics and bacterial infections. Cold Spring Harb. Perspect. Med. 2012, 2:a010272.
36. Rakoff-Nahoum S., et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
37. Takahashi K., et al. Epigenetic control of the host gene by commensal bacteria in large intestinal epithelial cells. J. Biol. Chem. 2011, 286:35755-35762.
38. Olszak T., et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012, 336:489-493.
39. Obata Y., et al. The epigenetic regulator Uhrf1 facilitates the proliferation and maturation of colonic regulatory T cells. Nat. Immunol. 2014, 15:571-579.
40. Ganal S.C., et al. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity 2012, 37:171-186.
41. Chen H., et al. HATs on and beyond chromatin. Curr. Opin. Cell Biol. 2001, 13:218-224.
42. Dhalluin C., et al. Structure and ligand of a histone acetyltransferase bromodomain. Nature 1999, 399:491-496.
43. Owen D.J., et al. The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p. EMBO J. 2000, 19:6141-6149.
44. Eberharter A., Becker P.B. Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep. 2002, 3:224-229.
45. Haberland M., et al. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 2009, 10:32-42.
46. Sauve A.A., et al. The biochemistry of sirtuins. Annu. Rev. Biochem. 2006, 75:435-465.
47. Choudhary C., et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009, 325:834-840.
48. You S.H., et al. The interaction between nuclear receptor corepressor and histone deacetylase 3 regulates both positive and negative thyroid hormone action in vivo. Mol. Endocrinol. 2010, 24:1359-1367.
49. Sun Z., et al. Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor. Mol. Cell 2013, 52:769-782.
50. Donohoe D.R., Bultman S.J. Metaboloepigenetics: interrelationships between energy metabolism and epigenetic control of gene expression. J. Cell. Physiol. 2012, 227:3169-3177.
51. Perissi V., Rosenfeld M.G. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat. Rev. Mol. Cell Biol. 2005, 6:542-554.
52. Kim G.W., et al. Dietary, metabolic, and potentially environmental modulation of the lysine acetylation machinery. Int. J. Cell Biol. 2010, 2010. 10.1155/2010/632739.
53. Dashwood R.H., Ho E. Dietary histone deacetylase inhibitors: from cells to mice to man. Semin. Cancer Biol. 2007, 17:363-369.
54. Chen X., et al. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E2865-E2874.
55. Wilson A.J., et al. Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J. Biol. Chem. 2006, 281:13548-13558.
56. Tou L., et al. Regulation of mammalian epithelial differentiation and intestine development by class I histone deacetylases. Mol. Cell. Biol. 2004, 24:3132-3139.
57. Alenghat T., et al. Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis. Nature 2013, 504:153-157.
58. Kobayashi T., et al. IL-10 regulates Il12b expression via histone deacetylation: implications for intestinal macrophage homeostasis. J. Immunol. 2012, 189:1792-1799.
59. Turgeon N., et al. HDAC1 and HDAC2 restrain the intestinal inflammatory response by regulating intestinal epithelial cell differentiation. PLoS ONE 2013, 8:e73785.
60. Turgeon N., et al. The acetylome regulators Hdac1 and Hdac2 differently modulate intestinal epithelial cell dependent homeostatic responses in experimental colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2014, 306:G594-G605.
61. Cummings J.H., et al. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987, 28:1221-1227.
62. Vinolo M.A., et al. Regulation of inflammation by short chain fatty acids. Nutrients 2011, 3:858-876.
63. Macfarlane S., Macfarlane G.T. Regulation of short-chain fatty acid production. Proc. Nutr. Soc. 2003, 62:67-72.
64. Maslowski K.M., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009, 461:1282-1286.
65. Smith P.M., et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013, 341:569-573.
66. Kim M.H., et al. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 2013, 145:396-406.
67. Trompette A., et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 2014, 20:159-166.
68. Chang P.V., et al. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:2247-2252.
69. Arpaia N., et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013, 504:451-455.
70. Furusawa Y., et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013, 504:446-450.
71. Hoverstad T., Midtvedt T. Short-chain fatty acids in germfree mice and rats. J. Nutr. 1986, 116:1772-1776.
72. Fukuda S., et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011, 469:543-547.
73. Atarashi K., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331:337-341.
74. Candido E.P., et al. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 1978, 14:105-113.
75. Waldecker M., et al. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J. Nutr. Biochem. 2008, 19:587-593.
76. de Zoeten E.F., et al. Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice. Gastroenterology 2010, 138:583-594.
77. Tao R., et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 2007, 13:1299-1307.
78. Glauben R., et al. Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice. Gut 2008, 57:613-622.
79. Beier U.H., et al. Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms. Sci. Signal. 2012, 5:ra45.
80. Roger T., et al. Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood 2011, 117:1205-1217.
81. Jeong Y., et al. Histone deacetylase isoforms regulate innate immune responses by deacetylating mitogen-activated protein kinase phosphatase-1. J. Leukoc. Biol. 2014, 95:651-659.
82. Glass C.K., Saijo K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat. Rev. Immunol. 2010, 10:365-376.
83. Berndt B.E., et al. Butyrate increases IL-23 production by stimulated dendritic cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 303:G1384-G1392.
84. Hamer H.M., et al. Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission. Clin. Nutr. 2010, 29:738-744.
85. Diehl G.E., et al. Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi) cells. Nature 2013, 494:116-120.
86. Tarrerias A.L., et al. Short-chain fatty acid enemas fail to decrease colonic hypersensitivity and inflammation in TNBS-induced colonic inflammation in rats. Pain 2002, 100:91-97.
87. Wellen K.E., Thompson C.B. Cellular metabolic stress: considering how cells respond to nutrient excess. Mol. Cell 2010, 40:323-332.
88. Wellen K.E., et al. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 2009, 324:1076-1080.
89. Simon G.M., et al. Quantitative assessment of the impact of the gut microbiota on lysine epsilon-acetylation of host proteins using gnotobiotic mice. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:11133-11138.
90. Huang L. Targeting histone deacetylases for the treatment of cancer and inflammatory diseases. J. Cell. Physiol. 2006, 209:611-616.
91. Falkenberg K.J., Johnstone R.W. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat. Rev. Drug Discov. 2014, 13:673-691.
92. Ververis K., et al. Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents. Biologics 2013, 7:47-60.
93. Bode K.A., Dalpke A.H. HDAC inhibitors block innate immunity. Blood 2011, 117:1102-1103.